P21579 (SYT1_HUMAN) Homo sapiens (Human)
Synaptotagmin-1 UniProtKBInterProSTRINGInteractive Modelling
422 aa; Sequence (Fasta) ;
17 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of Synaptotagmin-1 with SV2A peptide phosphorylated at Thr84 |
Heteromer Q7L0J3; | 3×CA; 1×GOL; | ||||
| Assess | ||||||
| Dynamic binding mode of a synaptotagmin-1-SNARE complex in solution |
Heteromer P32851; P60880; P63045; | |||||
| Assess | ||||||
| FGF-1-C2A binary complex structure: a key component in the fibroblast growthfactor non-classical pa… |
Heteromer P05230; | |||||
| Assess | ||||||
| The FGF1-S100A13-C2A hetero-hexameric complex structure: A component in the non-classical pathway f… |
Heteromer P05230; Q99584; | |||||
| Assess | ||||||
| S100A13-C2A binary complex structure |
Heteromer Q99584; | |||||
| Assess | ||||||
| Crystal structure of an engineered Botulinum Neurotoxin type B mutant E1191M/S1199Y in complex with… |
Heteromer P10844; | 3×GOL; 1×MLI; | ||||
| Assess | ||||||
| Nanobody (NbLumSyt1) bound to human Syt1 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of the binding domain of Botulinum Neurotoxin type B in complex with human synapt… |
Heteromer P10844; | |||||
| Assess | ||||||
| Crystal structure of the binding domain of Botulinum Neurotoxin type B mutant I1248W/V1249W in comp… |
Heteromer P10844; | 1×BGC; | ||||
| Assess | ||||||
| Binding domain of Botulinum neurotoxin DC in complex with human synaptotagmin I |
Heteromer Q9LBR1; | 6×SO4; 4×GOL; | ||||
| Assess | ||||||
| Botulinum neurotoxin B2 binding domain in complex with human synaptotagmin I |
Heteromer Q8GR96; | |||||
| Assess | ||||||
| Crystal structure analysis of human synaptotagmin 1 C2A-C2B | homo-2-mer | 8×CL; | ||||
| Assess | ||||||
| Human Synaptotagmin-1 C2A Y181F Ca2+ bound | homo-2-mer | 3×CA; | ||||
| Assess | ||||||
| Solution structure of C2B with IP6 | monomer | 1×IHP; | ||||
| Assess | ||||||
| 1.4 A structure of a pathogenic human Syt 1 C2B (D366E) | monomer | 4×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Human Synaptotagmin 1 C2B without Ca2+ | monomer | 3×SO4; | ||||
| Assess | ||||||
| 1.3 A structure of a pathogenic human Syt 1 C2B (I368T) | monomer | 9×SO4; | ||||
| Assess | ||||||
| Human Synaptotagmin-1 C2B Y312F without Ca2+ | monomer | 1×SO4; | ||||
| Assess | ||||||
| 1.7 angstrom structure of a pathogenic human Syt 1 C2B (D304G) | monomer | 5×SO4; | ||||
| Assess | ||||||
| C2A domain of synaptototagmin I solution structure in the FGF-1-C2A binary complex: key component i… | monomer | |||||
| Assess | ||||||
| Crystal Structure of Synaptotagmin I C2A domain | monomer | 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Synaptotagmin I C2A domain with Cu(II) | monomer | 2×CU; 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Synaptotagmin I C2A domain with Mn(II) | monomer | 1×SO4; 1×MN; | ||||
| Assess | ||||||
| Crystal Structure of Synaptotagmin I C2A domain with Cu(II) | monomer | 2×SO4; 2×CU; | ||||
| Assess | ||||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2r83.1.A | monomer | 0.84 | 99.65 | |||
| Assess | ||||||
| 5cch.1.E | monomer | 0.79 | 3×CA; | 100.00 | ||
| Assess | ||||||
| 5ccg.1.F | monomer | 0.78 | 3×CA; | 100.00 | ||
| Assess | ||||||
| 2m3e.1.A | monomer | 0.61 | 20.00 | |||
| Assess | ||||||
| 4kbb.1.B | monomer | 0.60 | 52.78 | |||
| Assess | ||||||